sEphB4

sEphB4 · Vasgene Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for sEphB4, covering 2024-05-02 to 2024-05-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma [Phase 2]